Antimicrobial resistance (AMR) is the resistance of a microorganism to an antimicrobial medicine to which it was previously sensitive. It develops when a microorganism mutates or acquires a resistance gene. Resistant organisms (including bacteria, viruses, fungi, protozoa and helminths) are able to withstand attack by antimicrobial medicines such as antibiotics, antivirals and antimalarials, so that standard treatments become ineffective and infections persist and may spread to other people.About AMR
Top storyWHO/Europe launches online course for clinicians on prescribing and using antibiotics wisely
WHO/Europe has launched a newly developed online course that aims to equip clinicians with the information they need to prescribe antibiotics appropriately and wisely. This free course, titled “Antimicrobial stewardship: A competency-based approach”, is available via the OpenWHO platform.
- Day 4 highlights: countries at the centre of health work
- Crown Princess of Denmark to address WHO/Europe’s annual meeting of ministers
- Second EVIPNet Europe cohort of countries to develop evidence-informed policy on AMR
- Cross-programme consultation: medication safety – the contribution of primary care in reducing antimicrobial resistance
Daphne Deckers: Treat antibiotics with careMore multimedia
InfographicDownload this infographic
Key resourceCentral Asian and Eastern European Surveillance on Antimicrobial Resistance (CAESAR)
A joint initiative to survey, contain and prevent the emergence and spread of antibiotic resistance in the European Region.Read more
Join the conversation
PublicationsCentral Asian and Eastern European Surveillance of Antimicrobial Resistance. Annual report 2017 More publications
Data and statistics
The number of people out of 400 000 who die every year in the European Region due to an infection with a resistant bacterial strain.
More data and statistics